Article By:
Vivian Lewis
Monday, March 28, 2016 7:51 AM EDT
The obvious strong buys include GlaxoSmithKline, a global pharmaceutical, vaccine, and nostrum seller; Vodafone, a UK-based player in telecoms in Africa, India, and Europe; plus BP plc, the oil company.